Anti-ferroptosis exosomes engineered for targeting M2 microglia to improve neurological function in ischemic stroke

Yong Wang,Zhuohang Liu,Luyu Li,Zengyu Zhang,Kai Zhang,Min Chu,Yang Liu,Xueyu Mao,Di Wu,Dongsheng Xu,Jing Zhao
DOI: https://doi.org/10.1186/s12951-024-02560-y
IF: 10.2
2024-05-28
Journal of Nanobiotechnology
Abstract:Stroke is a devastating disease affecting populations worldwide and is the primary cause of long-term disability. The inflammatory storm plays a crucial role in the progression of stroke. In the acute phase of ischemic stroke, there is a transient increase in anti-inflammatory M2 microglia followed by a rapid decline. Due to the abundant phospholipid in brain tissue, lipid peroxidation is a notable characteristic of ischemia/reperfusion (I/R), constituting a structural foundation for ferroptosis in M2 microglia. Slowing down the decrease in M2 microglia numbers and controlling the inflammatory microenvironment holds significant potential for enhancing stroke recovery.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?
This paper aims to address the issue of ferroptosis in ischemic stroke and explore a novel therapeutic approach. Specifically, researchers found that during the acute phase of ischemic stroke, the number of anti-inflammatory M2 microglia initially increases briefly and then rapidly decreases. Since ferroptosis is highly sensitive in M2 microglia, inhibiting ferroptosis in existing M2 microglia may help slow their reduction, thereby suppressing the inflammatory microenvironment and promoting neuronal survival. To achieve this goal, researchers developed an engineered exosome, M2pep-ADSC-Exo, which can specifically target M2 microglia and inhibit their ferroptosis. Through adipose-derived stem cell exosomes (ADSC-Exo), researchers found that it can regulate ferroptosis in M2 microglia by modulating the Fxr2/Atf3/Slc7a11 signaling axis and suppress the inflammatory microenvironment, thereby improving neurological function recovery after ischemic stroke. In summary, the main objective of this paper is to develop new methods for treating ischemic stroke by inhibiting ferroptosis in M2 microglia and to validate the efficacy and specificity of M2pep-ADSC-Exo.